ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

RMTI vs FLNA // RETURN ON INVESTED CAPITAL (ROIC)

Rockwell Medical Inc. (NASDAQ) VS. Filana Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: RMTI 4 — FLNA 0
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: RMTI
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RMTI VS. FLNA) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC RMTI FLNA SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 16.90% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) ACTIVE -10.60% -35.00% +24.40 RMTI /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -2.24% — — TIE /fcf-yield <GO>
Operating Margin -6.80% — — TIE /operating-margins <GO>
Net Profit Margin -7.70% — — TIE /net-margins <GO>
Revenue Growth (YoY) — — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 2/9 +1.00 RMTI /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 39.8 33.8 +6.00 RMTI /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $27.9M $27.1M $749.8K RMTI /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR RMTI REV FLNA REV RMTI GROSS % FLNA GROSS % RMTI FCF FLNA FCF
FY 2025 $69.3M $267.1M 16.9% — -$659.0K -$32.8M
FY 2024 $101.5M $396.0M 17.2% — $4.2M -$117.0M
FY 2023 $18.7M $296.7M — — -$9.4M -$82.0M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RMTI // BETA —
FLNA // BETA —